Trends for Pharmacists to Monitor

Sheila Arquette, RPh, director of Pharmacy Services for Independent Health, discusses developments in the specialty pharmacy landscape for stakeholders to monitor.

Related Videos

Related Content

Advertisement

October 29th 2024

Oral Semaglutide Reduces Risk of MACE for Patients With Type 2 Diabetes

Ashley Gallagher, Associate Editor

October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

October 25th 2024

Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy

Kennedy Ferruggia, Assistant Editor

September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Published: October 25th 2024 | Updated: October 25th 2024

FDA Grants Orphan Drug Designation to MDL-101 for Congenital Muscular Dystrophy Type 1a

Gillian McGovern, Assistant Editor

October 24th 2024

Women Beginning Chemotherapy for Breast Cancer Self-Report Improved Cognitive Function When Participating in Aerobic Exercise

Gillian McGovern, Assistant Editor

Related Content

Advertisement

October 29th 2024

Oral Semaglutide Reduces Risk of MACE for Patients With Type 2 Diabetes

Ashley Gallagher, Associate Editor

October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

October 25th 2024

Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy

Kennedy Ferruggia, Assistant Editor

September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Published: October 25th 2024 | Updated: October 25th 2024

FDA Grants Orphan Drug Designation to MDL-101 for Congenital Muscular Dystrophy Type 1a

Gillian McGovern, Assistant Editor

October 24th 2024

Women Beginning Chemotherapy for Breast Cancer Self-Report Improved Cognitive Function When Participating in Aerobic Exercise

Gillian McGovern, Assistant Editor